MTOR and neoplasm: Genes that encode components of the PI3K–Akt–mTOR pathway are frequently mutated in cancer, but despite few mutations have been characterized in mTOR, many tumor types present mTOR hyperactivation, thus promoting tumorigenesis (60, 61).